Ginkgo biloba and cognitive decline.
Lei Feng
Other
JAMA
2010
3 citações
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'pmid\u003D20407051';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Resumo Rápido
Results from both articles of the GEM study support the idea that a single agent administered in late life is not likely to be effective in the prevention of cognitive decline, since multiple factors across the life course influence an individual’s brain function in latelife.
Used In Evidence Reviews
Similar Papers
Pharmacological research · 1999
Health benefits of docosahexaenoic acid (DHA).
1060 citations
Circulation · 2010
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
593 citations
Contemporary clinical trials · 2012
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
522 citations
Open Access
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
Isorhamnetin: A review of pharmacological effects.
427 citations
Open Access
Archives of physical medicine and rehabilitation · 2000
Ginkgo biloba extract: mechanisms and clinical indications.
408 citations
Journal of clinical hypertension (Greenwich, Conn.) · 2011
Role of mercury toxicity in hypertension, cardiovascular disease, and stroke.
396 citations
Open Access